Eagle Meds Services
LYTGOBI (FUTIBATINIB)
Available to sourceHuman Prescription DrugOncology & Specialty

LYTGOBI (FUTIBATINIB)

4 mg/1 · Tablet
By TAIHO PHARMACEUTICAL CO., LTD.
NDC
64842-0120
Route
Oral
Therapeutic class
Breast Cancer Resistance Protein Inhibitors [MoA], Fibroblast Growth Factor Receptor Inhibitors [MoA], Kinase Inhibitor , P-Glycoprotein Inhibitors [MoA]
Marketing category
NDA

Package sizes

  • 1 BLISTER PACK in 1 CARTON (64842-0120-4) / 21 TABLET in 1 BLISTER PACKNDC 64842-0120-4Available to order
  • 1 BLISTER PACK in 1 CARTON (64842-0120-5) / 28 TABLET in 1 BLISTER PACKNDC 64842-0120-5Available to order
  • 1 BLISTER PACK in 1 CARTON (64842-0120-6) / 35 TABLET in 1 BLISTER PACKNDC 64842-0120-6Available to order

Additional information

Full prescribing information for this product is available on request. Submit a sourcing request and our team will share lot details, dating, and current pricing.

Request this medication

Send a request and we'll respond with availability, lot details, and pricing within 2 business hours.

Requesting
LYTGOBI (FUTIBATINIB)
NDC 64842-0120
(980) 480-3410 requests@eaglemedsservices.com

Related in Oncology & Specialty

See all →
Verzenio (abemaciclib)

Verzenio (abemaciclib)

50 mg/1 · Tablet
Eli Lilly and Company
Available to source
Verzenio (abemaciclib)

Verzenio (abemaciclib)

200 mg/1 · Tablet
Eli Lilly and Company
Available to source
Verzenio (abemaciclib)

Verzenio (abemaciclib)

100 mg/1 · Tablet
Eli Lilly and Company
Available to source
Verzenio (abemaciclib)

Verzenio (abemaciclib)

150 mg/1 · Tablet
Eli Lilly and Company
Available to source